By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > General > Oxybutynin

Oxybutynin

GMJ
Last updated: 02/06/2026 14:30
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|659 words

Oxybutynin

What is Oxybutynin?

Oxybutynin is an anticholinergic medication that belongs to a class of drugs called antispasmodics or antimuscarinic agents. It is primarily used to treat symptoms of overactive bladder, including frequent urination, urgency, and urinary incontinence. The medication works by relaxing the smooth muscles of the bladder to reduce unwanted bladder contractions.

Uses

Oxybutynin is prescribed for several urological conditions:

Overactive bladder syndrome: The most common use, helping to control symptoms like sudden urges to urinate, frequent urination, and involuntary urine leakage.

Neurogenic bladder dysfunction: Used in patients with spinal cord injuries, multiple sclerosis, or other neurological conditions that affect bladder control.

Submit Your Paper
GMJ_Submit_Banner

Urinary incontinence: Particularly effective for urge incontinence, where patients experience sudden, intense urges to urinate followed by involuntary loss of urine.

Pediatric enuresis: Sometimes prescribed for children with bladder control issues, particularly those with neurogenic bladder conditions.

Hyperhidrosis: In topical form, oxybutynin may be used off-label to treat excessive sweating in certain areas of the body.

How it works

Oxybutynin blocks muscarinic receptors in the smooth muscle of the bladder wall, preventing the neurotransmitter acetylcholine from binding to these receptors. This action reduces involuntary bladder muscle contractions and increases bladder capacity. The medication also has some local anesthetic properties that may contribute to its effectiveness in reducing bladder sensitivity.

Side effects

Common side effects include:

  • Dry mouth
  • Constipation
  • Drowsiness or dizziness
  • Blurred vision
  • Nausea
  • Headache
  • Dry eyes
  • Fatigue

Serious side effects to watch for:

  • Severe allergic reactions with difficulty breathing or swelling
  • Confusion, memory problems, or hallucinations, especially in elderly patients
  • Severe constipation or inability to urinate
  • Rapid or irregular heartbeat
  • Signs of heat stroke due to decreased sweating ability

Warnings and precautions

Patients with narrow-angle glaucoma should avoid oxybutynin as it can worsen this condition by increasing intraocular pressure. Individuals with severe gastrointestinal disorders, including bowel obstruction or severe ulcerative colitis, should not use this medication as it can slow intestinal movement.

Elderly patients require careful monitoring as they are more susceptible to anticholinergic side effects, including confusion, memory impairment, and falls. The medication should be used cautiously in patients with dementia or cognitive impairment.

Oxybutynin is classified as pregnancy category B, meaning animal studies have not shown harm to the fetus, but adequate human studies are lacking. Nursing mothers should consult their healthcare provider as the drug may pass into breast milk.

Patients with liver or kidney impairment may need dosage adjustments, as these organs are responsible for metabolizing and eliminating the medication from the body.

Interactions

Other anticholinergic medications such as antihistamines, tricyclic antidepressants, and antipsychotics can increase the risk of side effects when combined with oxybutynin.

Potassium supplements or potassium-sparing diuretics may increase the risk of gastrointestinal irritation and should be used cautiously together.

Alcohol and sedating medications can enhance the drowsiness and dizziness effects of oxybutynin, increasing the risk of falls and accidents.

CYP3A4 inhibitors like ketoconazole, clarithromycin, and grapefruit juice can increase oxybutynin blood levels, potentially leading to increased side effects.

Cholinesterase inhibitors used for dementia, such as donepezil, may have reduced effectiveness when used with oxybutynin due to opposing mechanisms of action.

Bisphosphonates taken orally may cause increased gastrointestinal irritation when combined with oxybutynin due to slowed stomach emptying.

Check interactions with the GMJ Interaction Checker

Dosage

For adults with overactive bladder, the typical starting dose is 5 mg taken 2-3 times daily, or 5-10 mg once daily for extended-release formulations. The maximum recommended dose is usually 20 mg per day for immediate-release tablets or 30 mg daily for extended-release forms. Elderly patients often start with lower doses due to increased sensitivity to side effects. Dosage adjustments should always be made under medical supervision, and patients should work closely with their healthcare provider to find the most effective dose with the fewest side effects.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Oxybutynin." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/oxybutynin/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
FDA’s Pazdur Calls for Agency Restructuring Amid China Competition and Internal Upheaval

FDA's Rick Pazdur calls for fundamental agency restructuring following internal disruption, citing…

Revolution Medicines Ships Experimental Pancreatic Cancer Drug Under Early Access

Revolution Medicines begins expanded access program for daraxonrasib targeting KRAS G12C mutations.…

NHS Patient Watchdog Abolition Sparks Concerns Over Health Service Accountability

Local councils warn that government plans to abolish NHS patient watchdogs will…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Baclofen

By
Prof. Giorgi Pkhakadze
02/06/2026

Carbamazepine

By
Prof. Giorgi Pkhakadze
02/06/2026

Ergotamine

By
Prof. Giorgi Pkhakadze
02/06/2026

Tizanidine

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up